Literature DB >> 15998998

Neonatal sepsis in Egypt associated with bacterial contamination of glucose-containing intravenous fluids.

Kelly L Moore1, Marion A Kainer, Nadia Badrawi, Salma Afifi, Momtaz Wasfy, Moataza Bashir, William R Jarvis, Tae Wha Graham, Amani el-Kholy, Reginald Gipson, Daniel B Jernigan, Frank Mahoney.   

Abstract

BACKGROUND: Rates of sepsis exceeding 50% in a neonatal intensive care unit (NICU) in Cairo, Egypt, were not controlled by routine antimicrobial therapy. We investigated these conditions in September 2001.
METHODS: Case series and retrospective cohort studies were conducted on 2 groups of NICU infants admitted to an academic medical center between February 12 and July 31, 2001. Observation of clinical practices led us to culture in-use intravenous (i.v.) fluids and medications. We monitored rates of i.v. fluid contamination, clinical sepsis and mortality after interventions to establish new procedures for handling and disposal of i.v. fluids, infection control training and improved clinical laboratory capacity.
RESULTS: Among infants in the retrospective cohort group, 88 (77%) of 115 had clinical sepsis, and 59 (51%) died. In the case series group, we documented the time of initial positive blood culture; 21 (64%) of 33 were septic <24 hours after birth. Klebsiella pneumoniae accounted for 24 (73%) of 33 isolates; 14 (58%) of 24 were extended spectrum beta-lactamase-producing and aminoglycoside-resistant. On admission, all neonates received glucose-containing i.v. fluids; i.v. bottles (500 mL) were divided among multiple infants. The i.v. fluids were prepared at the bedside; poor hand hygiene and poor adherence to aseptic techniques were observed. K. pneumoniae was isolated from 13 (65%) of 20 in-use glucose-containing i.v. fluids. Fluid contamination, sepsis and mortality rates declined significantly after intervention.
CONCLUSION: Extrinsically contaminated i.v. fluids resulted in sepsis and deaths. Standard infection control precautions significantly improve mortality and sepsis rates and are prerequisites for safe NICU care.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15998998     DOI: 10.1097/01.inf.0000168804.09875.95

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  12 in total

1.  Genetic diversity of carbapenem-resistant Klebsiella Pneumoniae causing neonatal sepsis in intensive care unit, Cairo, Egypt.

Authors:  Doaa M Ghaith; Mai Mahmoud Zafer; Halaa Mufeed Said; Sherif Elanwary; Salwa Elsaban; Mohamed Hamed Al-Agamy; Marie Fe F Bohol; Mahmoud Mohamed Bendary; Ahmed Al-Qahtani; Mohammed N Al-Ahdal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-26       Impact factor: 3.267

Review 2.  Effect of case management on neonatal mortality due to sepsis and pneumonia.

Authors:  Anita K M Zaidi; Hammad A Ganatra; Sana Syed; Simon Cousens; Anne C C Lee; Robert Black; Zulfiqar A Bhutta; Joy E Lawn
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

3.  Epidemiology of Neonatal Sepsis and Implicated Pathogens: A Study from Egypt.

Authors:  Eman M Rabie Shehab El-Din; Mohamed M Adel El-Sokkary; Mohamed Reda Bassiouny; Ramadan Hassan
Journal:  Biomed Res Int       Date:  2015-06-04       Impact factor: 3.411

Review 4.  Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Klebsiella spp.: A Systematic Review and Meta-Analyses.

Authors:  Tirza C Hendrik; Anne F Voor In 't Holt; Margreet C Vos
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

5.  Emerging antimicrobial resistance in early and late-onset neonatal sepsis.

Authors:  Lamiaa Mohsen; Nermin Ramy; Dalia Saied; Dina Akmal; Niveen Salama; Mona M Abdel Haleim; Hany Aly
Journal:  Antimicrob Resist Infect Control       Date:  2017-06-13       Impact factor: 4.887

6.  Extensively-Drug Resistant Klebsiella pneumoniae Recovered From Neonatal Sepsis Cases From a Major NICU in Egypt.

Authors:  Noha A Hassuna; Reem A AbdelAziz; Amira Zakaria; Mohammed Abdelhakeem
Journal:  Front Microbiol       Date:  2020-06-19       Impact factor: 5.640

7.  Characterization of CTX-M ESBLs in Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae clinical isolates from Cairo, Egypt.

Authors:  Noha G Khalaf; Mona M Eletreby; Nancy D Hanson
Journal:  BMC Infect Dis       Date:  2009-06-04       Impact factor: 3.090

8.  Detection of new SHV-12, SHV-5 and SHV-2a variants of extended spectrum beta-lactamase in Klebsiella pneumoniae in Egypt.

Authors:  Enas A Newire; Salwa F Ahmed; Brent House; Esmeralda Valiente; Guillermo Pimentel
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-07-18       Impact factor: 3.944

9.  Molecular characterization of multidrug-resistant Gram-negative pathogens in three tertiary hospitals in Cairo, Egypt.

Authors:  Amani A El-Kholy; Samia A Girgis; Mervat A F Shetta; Dalia H Abdel-Hamid; Arwa R Elmanakhly
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-17       Impact factor: 3.267

10.  Antibiotic Resistance Patterns of Bacterial Isolates from Neonatal Sepsis Patients at University Hospital of Leipzig, Germany.

Authors:  Belay Tessema; Norman Lippmann; Matthias Knüpfer; Ulrich Sack; Brigitte König
Journal:  Antibiotics (Basel)       Date:  2021-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.